Literature DB >> 28989382

An audit of neonatal and infant hepatitis B immunisation and serological testing in two counties of England, 2007-12.

Charles Richard Beck1,2, Vanessa MacGregor3, Sophia Makki3, Richard Puleston1,2.   

Abstract

We audited adherence to national hepatitis B virus (HBV) immunisation policy for neonates and infants born to HBV positive mothers in two counties of England during 2007/08 to 2011/12 (n=112 in County X, n=190 in County Y). Over the five year period, 29.9% of at risk neonates in County X and 23.5% in County Y required hepatitis B immunoglobulin (HBIG) at birth. The annual median age of HBIG administration was 0.0-0.5 days. The annual median coverage and timeliness of the first (coverage range 92.3-100.0%; age of administration range 0.0-0.0 days), second (83.8-100.0%; 32.0-42.0 days), third (81.1-100.0%; 62.0-81.0 days) and fourth dose HBV immunisations (44.4-91.9%; 378.0-443.0 days) and serological testing (8.6-81.0%; 450.0-707.0 days) were calculated. Statistically significant variation was found in the coverage of third and fourth dose immunisations in County Y, age of fourth dose immunisation in County X, and the coverage and timeliness of serological testing in both counties (p < 0.05). HBIG and the first three HBV immunisations were commonly administered according to the national schedule. Fourth dose immunisations and serological tests showed poor adherence. We advocate public health interventions to improve immunisation programme outcomes and hepatitis B surface antigen testing.

Entities:  

Keywords:  Coverage; hepatitis; immunisation; infant; neonate; vaccination

Year:  2014        PMID: 28989382      PMCID: PMC5074225          DOI: 10.1177/1757177414541710

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  14 in total

1.  Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation.

Authors:  David Sloan; Mary Ramsay; Leonie Prasad; David Gelb; Chong Gee Teo
Journal:  Vaccine       Date:  2005-08-03       Impact factor: 3.641

2.  Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006.

Authors:  Isabelle Giraudon; Nadia Permalloo; Grainne Nixon; Andre Charlett; Sandra Cohuet; Sema Mandal; Mary Ramsay; Bharat C Patel; Helen Maguire
Journal:  Vaccine       Date:  2009-01-09       Impact factor: 3.641

3.  Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.

Authors:  N Craine; J Parry; J O'Toole; S D'Arcy; M Lyons
Journal:  J Viral Hepat       Date:  2008-09-26       Impact factor: 3.728

4.  Hepatitis B vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-10-01

5.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Authors:  Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis
Journal:  Int J Epidemiol       Date:  2005-10-25       Impact factor: 7.196

6.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Authors:  Susan T Goldstein; Miriam J Alter; Ian T Williams; Linda A Moyer; Franklyn N Judson; Karen Mottram; Michael Fleenor; Patricia L Ryder; Harold S Margolis
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

7.  Hepatitis B prevalence and risk factors for HBsAg carriage amongst Somali households in Liverpool.

Authors:  D Aweis; B J Brabin; N J Beeching; J E Bunn; C Cooper; K Gardner; C Iriyagolle; C A Hart
Journal:  Commun Dis Public Health       Date:  2001-12

Review 8.  Risks of chronicity following acute hepatitis B virus infection: a review.

Authors:  K C Hyams
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

9.  Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.

Authors:  H S Margolis; P J Coleman; R E Brown; E E Mast; S H Sheingold; J A Arevalo
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

10.  Dried blood spot sampling for hepatitis B virus serology and molecular testing.

Authors:  Sofiane Mohamed; Audrey Raimondo; Guillaume Pénaranda; Claire Camus; Denis Ouzan; Sophie Ravet; Marc Bourlière; Hacène Khiri; Patrick Dukan; Daniel Olive; Philippe Halfon
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.